C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/1997
09/02/1997	US5663070 Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM
09/02/1997	US5663060 Having procoagulant activity
09/02/1997	US5663059 Polynucleotide with code, gene expression
09/02/1997	US5663051 Separation apparatus and method
09/02/1997	US5662899 Prepared by culturing human monocytes and lymphocytes in a culture medium containing 1,25-dihydroxy vitamin d3 and granulocyte-macrophage colony stimulating factor
09/02/1997	US5662896 Directly administering a vector construct which directs the expression of antitumor agents
09/02/1997	US5662895 Method of administering human pluripotent hematopoietic colony stimulating factor
09/01/1997	CA2198978A1 Method for the in vitro production of bone
08/1997
08/28/1997	WO1997031116A2 Recombinant ribonuclease proteins
08/28/1997	WO1997031115A2 Synthetic hiv genes
08/28/1997	WO1997031113A1 Cell-based assay
08/28/1997	WO1997031108A1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein
08/28/1997	WO1997031100A1 Method for growing plant cells in liquid suspension cultures, and chemotherapeutic agents derived from plants
08/28/1997	WO1997031099A1 Human beta 2 integrin alpha subunit
08/28/1997	WO1997031017A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
08/28/1997	WO1997031015A1 Rat ob receptors and nucleotides encoding them
08/28/1997	WO1997030778A1 Novel artificial pancreas
08/28/1997	WO1997030715A1 Method for separating cells, especially platelets, and bag assembly therefor
08/28/1997	WO1997030713A1 Method and composition for inhibiting cellular irreversible changes due to stress
08/28/1997	WO1997030590A1 Cellular immunotherapy
08/28/1997	WO1997030582A1 Production of hydroxylated fatty acids in genetically modified plants
08/28/1997	WO1997026523A3 Detection of a leptin receptor variant and methods for regulating obesity
08/28/1997	WO1997020935A3 Viral vectors
08/28/1997	WO1997020051A3 Vectors and methods for gene transfer to cells
08/28/1997	WO1997016535A3 Methods for use of mpl ligands with primitive human stem cells
08/28/1997	CA2250029A1 Cellular immunotherapy
08/28/1997	CA2247517A1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein
08/28/1997	CA2247461A1 Method and composition for inhibiting cellular irreversible changes due to stress
08/28/1997	CA2246300A1 Cell-based assay
08/28/1997	CA2246226A1 Rat ob receptors and nucleotides encoding them
08/28/1997	CA2242859A1 Production of hydroxylated fatty acids in genetically modified plants
08/28/1997	CA2218623A1 Novel artificial pancreas
08/27/1997	EP0791653A1 Human Fc-gamma receptor III
08/27/1997	EP0791652A1 Transgenic mammals expressing polypeptide-containing substances in their milk
08/27/1997	EP0791205A1 Biological analysis system self-calibration apparatus
08/27/1997	EP0791078A1 Methods for drug screening
08/27/1997	EP0791077A1 Methods for modulating transcription from the amyloid beta-protein precursor (app) promoter
08/27/1997	EP0791076A1 Diagnostic method and kit for determining kell blood group genotype
08/27/1997	EP0791066A1 Dna molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules
08/27/1997	EP0791059A1 Production of recombinant peptides as natural hydrophobic peptide analogues
08/27/1997	EP0791058A1 Nucleotide sequence encoding the enzyme i-scei and the uses thereof
08/27/1997	EP0791056A2 Lipid-splitting enzyme
08/27/1997	EP0791054A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease
08/27/1997	EP0791053A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases
08/27/1997	EP0791052A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
08/27/1997	EP0791051A1 Neural cultures
08/27/1997	EP0791050A1 Vectors for tissue-specific replication
08/27/1997	EP0791010A1 Retroviral vectors containing recombinant cmv-ie/hiv-tar/moloney murine leukemia virus long terminal repeats
08/27/1997	EP0791009A1 Modified neuropeptide y receptors
08/27/1997	EP0790836A1 Serially passaged african green monkey kidney cells
08/27/1997	EP0790833A1 Process for identifying para cation channel modulators
08/27/1997	EP0790830A1 Trophinin and trophinin-assisting proteins
08/27/1997	EP0790768A1 In vitro tissue and organ equivalent models
08/27/1997	EP0790767A2 Wound repair dressings and methods for their preservation
08/27/1997	EP0700437B1 Dna encoding prostaglandin receptor ep1
08/27/1997	EP0637966B1 Bystander effect tumoricidal therapy
08/27/1997	EP0547203B1 In vivo delivery of active factors by co-cultured cell implants
08/27/1997	CN1158134A Antibodies which activate an erythropoietin receptor
08/27/1997	CN1157827A Novel, ATP-sensitive potassium-channel proteins and genes for the same
08/27/1997	CN1157826A Novel, ubiquitous potassium-channel proteins and genes for the same
08/26/1997	US5661135 Human VEGF-specific oligonucleotides
08/26/1997	US5661034 Serum-free medium for tissue culture containing tissue inhibitor of metalloproteinases and method for growing cells using the medium
08/26/1997	US5661032 Controller of transcription of marker gene
08/26/1997	US5661023 Ion exchanging and elution to recover retroviruses for vaccines
08/26/1997	US5661015 Recombinant coccidiosis vaccines
08/26/1997	US5661007 Culturing; recovering; purification; administering to induce bone and/or cartilage formation
08/26/1997	US5661006 Polynucleotides genetic engineering a vaccines
08/26/1997	US5661004 Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof
08/26/1997	US5661002 Modified transcription control unit and uses thereof
08/26/1997	US5660986 Immortalized human cell lines containing exogenous cytochrome P450 genes
08/26/1997	US5660850 Injecting suspension of cells, cultured from skin biopsies of subject and treated with proteolytic enzymes, into defects or voids using hypodermic needles
08/26/1997	US5659984 Adapted to be attached to a vehicle
08/26/1997	CA1339363C Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
08/26/1997	CA1339354C Recombinant retroviruses with amphotropic and ecotropic host ranges
08/26/1997	CA1339350C Monoclonal antibody kc-57 to hiv core proteins
08/21/1997	WO1997030354A2 Foetal cell analysis
08/21/1997	WO1997030346A1 Creation and use of multiple gradients in electrophoresis in gel slabs and in capillaries
08/21/1997	WO1997030164A1 Improvements in or relating to gene expression
08/21/1997	WO1997030161A1 Hybrid proteins which form heterodimers
08/21/1997	WO1997030160A1 Esterases
08/21/1997	WO1997030159A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
08/21/1997	WO1997030158A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
08/21/1997	WO1997030153A1 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas
08/21/1997	WO1997030151A1 Cytokine expressed by dia/lif-deficient embryonic stem cells for the inhibition of differentiation
08/21/1997	WO1997030149A1 Novel era
08/21/1997	WO1997030147A1 Human embryonic lung fibroblast diploid cell strain suitable for the production of virus and process for the production of varicella zoster virus using same
08/21/1997	WO1997030146A2 Cardiotrophin and uses therefor
08/21/1997	WO1997030083A1 Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions
08/21/1997	WO1997030074A1 Isolation and use of sh3 binding peptides
08/21/1997	WO1997030070A1 Novel compounds
08/21/1997	WO1997030065A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/21/1997	WO1997030024A2 Lipids and their use, for example, in liposomes
08/21/1997	WO1997029772A1 Recombinant canine herpesviruses
08/21/1997	WO1997029771A1 Immunogenic detoxified mutants of cholera toxin
08/21/1997	WO1997029766A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof
08/21/1997	WO1997029761A1 Method of producing bone-inducing agent
08/21/1997	WO1997023613A3 Cell activation process and reagents therefor
08/21/1997	WO1997023507A3 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
08/21/1997	WO1996040937A3 Adenosine kinase polynucleotides
08/21/1997	CA2247246A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease

1 ... 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 ... 1827